78 related articles for article (PubMed ID: 37403117)
1. Role of protein tyrosine phosphatase receptor type M in epithelial ovarian cancer progression.
Li X; Ding W; Rao Y; Qu P
J Ovarian Res; 2023 Jul; 16(1):131. PubMed ID: 37403117
[TBL] [Abstract][Full Text] [Related]
2. NLRP12 is a prognostic biomarker and correlated with immune infiltrates in epithelial ovarian cancer.
Ma R; Tang Z; Wang J
J Gene Med; 2024 Jan; 26(1):e3585. PubMed ID: 37926491
[TBL] [Abstract][Full Text] [Related]
3. [Expressions of OCT4, Notch1 and DLL4 and their clinical implications in epithelial ovarian cancer].
Yu L; Jiao YJ; Zhou L; Song WQ; Wu SW; Wang DN
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Apr; 37(4):444-450. PubMed ID: 28446394
[TBL] [Abstract][Full Text] [Related]
4. CD38 Predicts Favorable Prognosis by Enhancing Immune Infiltration and Antitumor Immunity in the Epithelial Ovarian Cancer Microenvironment.
Zhu Y; Zhang Z; Jiang Z; Liu Y; Zhou J
Front Genet; 2020; 11():369. PubMed ID: 32425977
[TBL] [Abstract][Full Text] [Related]
5. Cancer-associated fibroblasts-derived FMO2 as a biomarker of macrophage infiltration and prognosis in epithelial ovarian cancer.
Yu S; Yang R; Xu T; Li X; Wu S; Zhang J
Gynecol Oncol; 2022 Nov; 167(2):342-353. PubMed ID: 36114029
[TBL] [Abstract][Full Text] [Related]
6. High-expressed ACAT2 predicted the poor prognosis of platinum-resistant epithelial ovarian cancer.
Wang J; Yang Z; Bai H; Zhao L; Ji J; Bin Y; Liu Y; Zhang S; Hou H; Li Q
Diagn Pathol; 2024 Jan; 19(1):7. PubMed ID: 38178203
[TBL] [Abstract][Full Text] [Related]
7. Clinical value of bioelectrical properties of cancerous tissue in advanced epithelial ovarian cancer patients.
Cunnea P; Gorgy T; Petkos K; Gowers SAN; Lu H; Morera C; Wu W; Lawton P; Nixon K; Leong CL; Sorbi F; Domenici L; Paterson A; Curry E; Gabra H; Boutelle MG; Drakakis EM; Fotopoulou C
Sci Rep; 2018 Oct; 8(1):14695. PubMed ID: 30279418
[TBL] [Abstract][Full Text] [Related]
8. Deep Learning Can Predict Bevacizumab Therapeutic Effect and Microsatellite Instability Directly from Histology in Epithelial Ovarian Cancer.
Wang CW; Lee YC; Lin YJ; Firdi NP; Muzakky H; Liu TC; Lai PJ; Wang CH; Wang YC; Yu MH; Wu CH; Chao TK
Lab Invest; 2023 Nov; 103(11):100247. PubMed ID: 37741509
[TBL] [Abstract][Full Text] [Related]
9. PRKDC-Mediated NHEJ May Play a Crucial Role in Aneuploidy of Chromosome 8-Driven Progression of Ovarian Cancer.
Luan W; Cheng H; Xie H; Liu H; Wang Y; Wang S; Ye X; Zhu H; Tang F; Li Y; Chang X
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732044
[TBL] [Abstract][Full Text] [Related]
10. Correlation between plasma PSGL-1 and FIGO stage, tumor metastasis, and survival in epithelial ovarian cancer.
Li W; Fang C; Gao Y; Gao Y; Yan F; Chen B; Xu M
Biotechnol Appl Biochem; 2024 Mar; ():. PubMed ID: 38494670
[TBL] [Abstract][Full Text] [Related]
11. Immune checkpoints as potential theragnostic biomarkers for epithelial ovarian cancer.
Habel A; Weili X; Hadj Ahmed M; Stayoussef M; Bouaziz H; Ayadi M; Mezlini A; Larbi A; Yaacoubi-Loueslati B
Int J Biol Markers; 2023 Dec; 38(3-4):203-213. PubMed ID: 37518940
[TBL] [Abstract][Full Text] [Related]
12. CX3CR1 is a potential biomarker of immune microenvironment and prognosis in epithelial ovarian cancer.
Shao D; Zhou H; Yu H; Zhu X
Medicine (Baltimore); 2024 Jan; 103(3):e36891. PubMed ID: 38241595
[TBL] [Abstract][Full Text] [Related]
13. Could uterine conservation be an option in presumed early-stage epithelial ovarian cancer?
Benoit L; Pajot C; Koual M; Nguyen-Xuan HT; Bentivegna E; Bats AS; Azaïs H
Arch Gynecol Obstet; 2023 Sep; 308(3):953-960. PubMed ID: 37031304
[TBL] [Abstract][Full Text] [Related]
14. Period Analysis of Intraracial Differences in Incidence and Survival Rates in Epithelial Ovarian Cancer.
Han L; Husaiyin S; Liu J; Maimaiti M; Niyazi M; Li L
Comput Math Methods Med; 2021; 2021():8032209. PubMed ID: 34925544
[TBL] [Abstract][Full Text] [Related]
15. [ENTPD5 gene is highly expressed in epithelial ovarian cancer: analysis based on Oncomine database and bioinformatics].
Wang H; Chen X; Chen Y; Cao Y; Chen Y; Liu G; Huang L
Nan Fang Yi Ke Da Xue Xue Bao; 2021 Apr; 41(4):555-561. PubMed ID: 33963715
[TBL] [Abstract][Full Text] [Related]
16. The polymorphism rs4705342 in the promoter of miR-143/145 is related to the risk of epithelial ovarian cancer and patient prognosis.
Zhao J; Zuo W; Zhang Y; He C; Zhao W; Meng T
Front Oncol; 2023; 13():1122284. PubMed ID: 37081985
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of INPP4B is Associated with Poor Prognosis in Epithelial Ovarian Carcinoma.
Jiang L; Wang J
Int J Gen Med; 2024; 17():1059-1072. PubMed ID: 38525069
[TBL] [Abstract][Full Text] [Related]
18. Prognostic performance of pretreatment systemic immune-inflammation index in women with epithelial ovarian cancer.
Okunade KS; John-Olabode SO; Soibi-Harry AP; Okoro AC; Adejimi AA; Ademuyiwa IY; Osunwusi B; Adelabu H; Salako O
Future Sci OA; 2023 Dec; 9(10):FSO897. PubMed ID: 37753357
[TBL] [Abstract][Full Text] [Related]
19. Epithelial ovarian cancer in younger age versus older age groups: Survival and clinicopathological features.
Kongkamsuan W; Boonyapipat S
J Cancer Res Ther; 2024 Jan; 20(1):363-368. PubMed ID: 38554347
[TBL] [Abstract][Full Text] [Related]
20. History of autoimmune disease and long-term survival of epithelial ovarian cancer: The extreme study.
Hannibal CG; Kjaer SK; Galanakis M; Hertzum-Larsen R; Maltesen T; Baandrup L
Gynecol Oncol; 2024 Mar; 182():1-6. PubMed ID: 38246041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
